Influence of bacteriophage preparations on intracellular killing of bacteria by human phagocytes in vitro

Viral Immunology

Volumn 26, Issue 2, 2013, Pages 150-162

  Kurzepa Skaradzinska, Aneta ^a,b   Lusiak Szelachowska, Marzanna ^a   Skaradzinski, Grzegorz ^a   Jonczyk Matysiak, Ewa ^a   Weber Dabrowska, Beata ^a   Zaczek, MacIej ^a   Maj, Tomasz ^a   Slawek, Anna ^a   Rymowicz, Waldemar ^b   Klak, Marlena ^a   Miedzybrodzki, Ryszard ^a   Gorski, Andrzej ^a,c  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL IMMUNITY; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; CELL LYSATE; CONTROLLED STUDY; ESCHERICHIA COLI; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR KILLING; MONOCYTE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PURIFICATION; SENSITIVITY ANALYSIS; STAPHYLOCOCCUS AUREUS;

BACTERIOPHAGE T4; ESCHERICHIA COLI; HUMANS; MICROBIAL VIABILITY; PHAGOCYTES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 84876104429     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2012.0071     Document Type: Article

References (50)

1. Harper DR, and Enright MC. Bacteriophages for treatment of Pseudomonas aeruginosa infections. J Appl Microbiol 2011; 111:1-7.
2. Lin NT, Chiou PY, Chang KC, Chen LK, and Lai MJ. Isolation and characterization of phi AB2: A novel bacteriophage of Acinetobacter baumannii. Res Microbiol 2010;161:308-314.
3. Gupta R, and Prasad Y. Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections. Curr Microbiol 2011;62:255-260.
4. Hsieh SE, Lo HH, Chen ST, Lee MC, and Tseng YH. Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2. Appl Environ Microbiol 2011;77: 756-761.
5. Morello E, Saussereau E, Maura D, Huerre M, Touqui L, and Debarbieux L. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: First steps towards treatment and prevention. PLoS One 2011;6:e16963.
6. Vinodkumar CS, Srinivasa H, Basavarajappa KG, Geethalakshmi S, and Bandekar N. Isolation of bacteriophages to multi-drug resistant Enterococci obtained from diabetic foot: A novel antimicrobial agent waiting in the shelf. Indian J Pathol Microbiol 2011;54:90-95.
7. Gilmore BF. Bacteriophages as anti-infective agents: Recent developments and regulatory challenges. Expert Rev Anti Infect Ther 2012;10:533-535.
8. Loc-Carrillo C, and Abedon ST. Pros and cons of phage therapy. Bacteriophage 2011;1:111-114.
9. Chan BK, and Abedon ST. Phage therapy and pharmacology phage coctails. Adv Appl Microbiol 2012;78:1-23.
10. Rakhuba DV, Kolomiets EI, Dey ES, and Novik GI. Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell. Pol J Microbiol 2010;59:145-155.
11. Savini V, Catavitello C, Astolfi D, et al. Bacterial contamination of platelets and septic transfusions: Review of the literature and discussion on recent patents about biofilm treatment. Recent Pat Antiinfect Drug Discov 2010;5: 168-176.
12. Housby JN, and Mann NH. Phage therapy. Drug Discov Today 2009;14:536-540.
13. Monk AB, Rees CD, Barrow P, Hagens S, and Harper DR. Bacteriophage applications: Where are we now? Lett Appl Microbiol 2010;51:363-369.
14. Kantoch M. Studies on phagocytosis of bacterial viruses I. Arch Immun Ther Exp 1958a;6:63.
15. Kantoch M. Studies on phagocytosis of bacterial viruses. II. Arch Immun Ther Exp 1958b;6:417.
16. Kantoch M, Skurski A, and Wieczorek Z. In vitro blockade of bacterial phagocytosis by means of bacterial viruses. Postepy Hig Med Dosw 1958;12:95-96.
17. Weber-Dabrowska B, Dabrowski M, and Slopek S. Studies on bacteriophage penetration in patients subjected to phage therapy. Arch Immunol Ther Exp 1987;35:563-568.
18. Weber-Dabrowska B, Zimecki M, and Mulczyk M. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch Immunol Ther Exp 2000;48:31-38.
19. Weber-Dabrowska B, Zimecki M, Mulczyk M, and Gorski A. Effect of phage therapy on the turnover and function of peripheral neutrophils. FEMS Immunol Med Microbiol 2002;34:135-138.
20. Gorski A, Dabrowska K, Switala-Jelen K, et al. New insights into the possible role of bacteriophages in host defense and disease. Med Immunol 2003;2:2.
21. Gorski A, Wazna E, Weber-Dabrowska B, Dabrowska K, Switala-Jelen K, and Miedzybrodzki R. Bacteriophage translocation. FEMS Immunol Med Microbiol 2006;46: 313-319.
22. Gorski A, Miedzybrodzki R, Borysowski J, et al. Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs 2009;10:766-774.
23. Miedzybrodzki R, Borysowski J, Weber-Dabrowska B, et al. Clinical aspects of phage therapy. Adv Virus Res 2012;83: 73-121.
24. Gorski A, Miedzybrodzki R, Borysowski J, et al. Phage as a modulator of immune response: practical implications for phage therapy. Adv Virus Res. 2012;83:41-71.
25. Carlson K, and Miller ES: 1994, Working with T4. pp 421-434
26. Karam JD (ed) Molecular Biology of Bacteriophage T4, American Society for Microbiology Press, Washington DC.
27. Boratynski J, Syper D, Weber-Dabrowska B, Lusiak-Szelachowska M, Pozniak G, and Gorski A. Preparation of endotoxin-free bacteriophages. Cell Mol Biol Lett 2004;9: 253-259. (Pubitemid 38902220)
28. Adams MH: 1959, Enumeration of bacteriophage particles. pp 27-30. In: Adams MH (ed) The Bacteriophages. Inter Science Publ, New York.
29. Westphal OJK. Bacterial lipopolysaccharides: Extraction with phenol-water and further applications of the procedure. Meth Carbohydr Chem 1965;5:83-89.
30. Boyum A. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968; 97:77-78.
31. Carlone NA, Cuffini AM, Tullio V, and Cavallo G. Interactions of antibiotics with phagocytes in vitro. J Chemother 1991;3:98-104.
32. Hauser WE Jr, and Remington JS. Effect of antibiotics on the immune response. Am J Med 1982;72:711-716. (Pubitemid 12112417)
33. Gillisen G. Side effects of antibiotics on immune response parameters and their possible implications in antimicrobal chemotherapy. Zentralbl Bakteriol Mikrobiol Hyg A 1988; 270:171-199.
34. Van den Broek PJ. Antimicrobal drugs, microorganisms, and phagocytes. Clin Infect Dis 1989;11:213-245.
35. Jirillo E, Greco B, Caradonna L, Satalino R, Amati L, Cozzolongo R, Cuppone R, and Manghisi OG. Immunological effects following administration of interferon-alpha in patients with chronic hepatitis C virus (cHCV) infection. Immunopharmacol Immunotoxicol 1996;18: 355-374. (Pubitemid 26284203)
36. Kharazmi A. Mechanisms involved in the evasion of the host defense by Pseudomonas aeruginosa. Immunol Lett 1991;30: 201-205.
37. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, and Jeffers AK. The exopolysaccharide alignate protects Pseudomonas aeruginosa biofilm bacteria from IFNgamma-mediated macrophage killing. J Immunol 2005;175: 7512-7518. (Pubitemid 41713449)
38. Brodsky IE, and Medzhitov R. Targeting of immune signaling networks by bacterial pathogens. Nat Cell Biol 2009;11: 521-526.
39. Sald?́as MS, Ortega X, and ValVano MA. Burkholderia cencocepacia O antygen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells. J Med Microbiol 2009;58:1542-1548.
40. Bateman SL, and Seed PC. Procession to pediatric bacteremia and sepsis: Covert operations and failures in diplomacy. Pediatrics 2010;126:137-150.
41. Roche Y, Fay M, and Gougerot-Pocidalo MA. Effects of quinolones on interleukin 1 production in vitro by human monocytes. Immunopharmacology 1987a;13:99-109. (Pubitemid 17052432)
42. Roche Y, Gougerot-Pocidalo MA, Fay M, Etienne D, Forest N, and Pocidalo JJ. Comparative effects of quinolones on human mononuclear leukocyte function. J Antimicrob Chemother 1987b;19:781-790. (Pubitemid 17092064)
43. Gillisen G. Side effects of antibiotics on immune response parameters and their possible implications in antimicrobial chemotherapy. Zentralbl Bakteriol Mikrobiol Hyg A 1988;270:171-199.
44. Doric M, Abram M, and Rukavina T. Antimicrobial activity and immunological side effects of different antibiotics. Folia Biol 1993;39:162-165. (Pubitemid 23359041)
45. Morikawa K, Oseko F, Morikawa S, and Iwamoto K. Immunomodulatory effects of the macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. Antimicrob Agents Chemother 1994;38:2643-2647. (Pubitemid 24332600)
46. Van Vlem B, Vanholder R, De Paepe P, Vogelaers D, and Ringoir S. Immunomodulating effects of antibiotics: Literature review. Infection 1996;24:275-291. (Pubitemid 26273294)
47. Khan AA, Slifer TR, and Remington JS. Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob Agents Chemother 1998;42:1713-1717. (Pubitemid 28311567)
48. Brandl K, Plitas G, Mihu CN, et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune defectis. Nature 2008;455:804-807.
49. Gorski A, and Mularczyk A. Neutrophil functions in renal transplant recipients. Arch Immunol Ther Exp 1978;26:975-979.
50. Greenblatt MB, Aliprantis A, Hu B, and Glimcher LH. Calcineurin regulates innate antifungal immunity in neutrophils. J Exp Med 2010;207:923-931.